COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,686 Articles (22,913 medRxiv, 8,773 bioRxiv)

Most recent first Previous |  Page 2699: Articles 26981-26990  | Next

How Should Clinicians Interpret Imprecise Trials Assessing Drugs for COVID-19 Patients?
Manski, C. F., Tetenov, A.
10.1101/2020.05.26.20114009 — Posted: 2020-06-05
Estimating the parameters of SIR model of COVID-19 cases in India during lock down periods
BAGAL, D. K., RATH, A., Barua, A., Patnaik, D.
10.1101/2020.06.03.20120899 — Posted: 2020-06-04
Integrated genomic view of SARS-CoV-2 in India
Kumar, P., Pandey, R., Sharma, P., Dhar, M., Vivekanand, A., Bharathram, U., Vashistha, H., Wadhwa, S., Tyagi, N., Fatihi, S., Sharma, U., Singh, P., Lall, H., Datta, M., Gupta, P., Saini, N., Tiwari, A., Nandi, B., Kumar, D., Bag, S., Deepanshi, D., Rathore, S., Jatana, N., Jaiswal, V., Gogia, H., Madan, P., Singh, S., Singh, P., Dash, D., Bala, M., Kabra, S., Singh, S. K., Mukerji, M., Thukral, L., Faruq, M., Agarwal, A., Rakshit, P.
10.1101/2020.06.04.128751 — Posted: 2020-06-04 Discussion: Onsite | Offsite
Olfactory transmucosal SARS-CoV-2 invasion as port of Central Nervous System entry in COVID-19 patients
Meinhardt, J., Radke, J., Dittmayer, C., Mothes, R., Franz, J., Laue, M., Schneider, J., Bruenink, S., Hassan, O., Stenzel, W., Windgassen,, M., Roessler, L., Goebel, H.-H., Martin, H., Nitsche, A., Schulz-Schaeffer, W., Hakroush, S., Winkler, M. S., Tampe, B., Elezkurtaj, S., Horst, D., Oesterhelweg, L., Tsokos, M., Ingold Heppner, B., Stadelmann, C., Drosten, C., Corman, V. M., Radbruch, H., Heppner, F. L.
10.1101/2020.06.04.135012 — Posted: 2020-06-04
Human iPSC-derived alveolar and airway epithelial cells can be cultured at air-liquid interface and express SARS-CoV-2 host factors
Abo, K. M., Ma, L., Matte, T., Huang, J., Alysandratos, K. D., Werder, R. B., Mithal, A., Beermann, M. L., Lindstrom-Vautrin, J., Mostoslavsky, G., Ikonomou, L., Kotton, D. N., Hawkins, F., Wilson, A., Villacorta-Martin, C.
10.1101/2020.06.03.132639 — Posted: 2020-06-04 Discussion: Onsite | Offsite
The Zinc Finger Antiviral Protein restricts SARS-CoV-2
Nchioua, R., Kmiec, D., Mueller, J., Conzelmann, C., Gross, R., Swanson, C. M., Neil, S., Stenger, S., Sauter, D., Muench, J., Sparrer, K. M., Kirchhoff, F.
10.1101/2020.06.04.134379 — Posted: 2020-06-04
SARS-CoV2 Testing: The Limit of Detection Matters
Arnaout, R., Lee, R., Lee, G. R., Callahan, C., Yen, C. F., Smith, K. P., Arora, R., Kirby, J. E.
10.1101/2020.06.02.131144 — Posted: 2020-06-04 Discussion: Onsite
Landscape and Selection of Vaccine Epitopes in SARS-CoV-2
Smith, C. C., Entwistle, S., Willis, C., Vensko, S., Beck, W., Garness, J., Sambade, M., Routh, E., Olsen, K., Kodysh, J., O'Donnell, T., Haber, C., Heiss, K., Stadler, V., Garrison, E., Grant, O. C., Woods, R., Heise, M., Vincent, B. G., Rubinsteyn, A.
10.1101/2020.06.04.135004 — Posted: 2020-06-04
Pitfalls in SARS-CoV-2 PCR diagnostics
Wernike, K., Keller, M., Conraths, F. J., Mettenleiter, T. C., Groschup, M. H., Beer, M.
10.1101/2020.06.03.132357 — Posted: 2020-06-04
Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in Colombia
Franco-Munoz, C., Alvarez-Diaz, D. A., Laiton-Donato, K., Wiesner, M., Escandon, P., Usme-Ciro, J. A., Franco-Sierra, N. D., Florez-Sanchez, A. C., Gomez-Rangel, S., Rodriguez Calderon, L. D., Barbosa Ramirez, J., Ospitia Baez, E., Walteros, D. M., Ospina Martinez, M. L., Mercado-Reyes, M.
10.1101/2020.06.02.20120782 — Posted: 2020-06-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).